Blog

The first global long COVID guideline: what it recommends

Long COVID has had no shortage of advice and very little agreement. In 2026, that changed: a new guideline was published in the *European Respiratory Journal*, written by 60 people from ten countries.

What it says

The guideline makes ten recommendations, each based on a systematic review.

To prevent long COVID, it suggests vaccination or antiviral treatment during the acute infection.

For treatment, it recommends against nirmatrelvir/ritonavir and against steroids for people with persistent breathing or smell problems.

It supports three things: multi-species probiotics, cognitive behavioural therapy for fatigue, and personalised rehabilitation.

The line that matters most

Personalised rehabilitation is recommended **after post-exertional malaise has been ruled out**.

That qualification is the whole point.

Rehabilitation and exercise-based programmes can help people whose problems are related to loss of fitness after being ill. For people who experience a significant worsening of symptoms after exertion, the same approach may not be appropriate.

Being asked about PEM before starting an activity programme is not an optional extra.

How certain is any of this?

Not very, and the guideline says so.

Every recommendation is based on evidence rated from very low to moderate certainty. These are recommendations based on the best available research, not settled facts.

That is not a reason to ignore them. It is a reason to treat any new treatment plan as something to test carefully, in small steps, and to stop if it makes you worse.

How common is long COVID?

A 2025 meta-analysis of 429 studies estimated that 36% of people develop long COVID after infection, with 46% still affected one to two years later. Fatigue was among the most common symptoms.

Being unvaccinated, infection with an earlier variant, and female sex were identified as the strongest risk factors.

If you are living with long COVID, you are not an unusual case.

Sources: Cao et al. *Clinical practice guideline for long COVID prevention and treatment.* European Respiratory Journal, 2026. [PubMed](https://pubmed.ncbi.nlm.nih.gov/41856572) — Hou et al. *Global prevalence of long COVID.* Open Forum Infectious Diseases, 2025. [PubMed](https://pubmed.ncbi.nlm.nih.gov/41018705)

This is general information and does not replace medical care. Speak to your doctor about your own health.

The first global long COVID guideline: what it recommends | Wellth Complex Care